Eric W. Hoffman

8.3k total citations
62 papers, 2.5k citations indexed

About

Eric W. Hoffman is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Eric W. Hoffman has authored 62 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 24 papers in Immunology and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Eric W. Hoffman's work include Immunotherapy and Immune Responses (23 papers), vaccines and immunoinformatics approaches (14 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). Eric W. Hoffman is often cited by papers focused on Immunotherapy and Immune Responses (23 papers), vaccines and immunoinformatics approaches (14 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). Eric W. Hoffman collaborates with scholars based in United States, Australia and Germany. Eric W. Hoffman's co-authors include Lloyd J. Old, Gerd Ritter, Sacha Gnjatic, Linda Pan, Alexander Knuth, Julia Karbach, Elke Jäger, Antje Neumann, Yasuhiro Nagata and Elisabeth Stockert and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Annals of Internal Medicine.

In The Last Decade

Eric W. Hoffman

59 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric W. Hoffman United States	26	1.5k	995	965	315	226	62	2.5k
Chang‐Yuil Kang South Korea	36	2.6k 1.8×	855 0.9×	1.1k 1.1×	442 1.4×	156 0.7×	119	3.9k
Peter L. Smith United States	23	1.2k 0.8×	1.2k 1.2×	546 0.6×	253 0.8×	151 0.7×	42	2.6k
Hans Sjögren Sweden	28	2.2k 1.5×	902 0.9×	1.1k 1.2×	707 2.2×	330 1.5×	142	4.0k
Sherif S. Farag United States	30	2.0k 1.4×	877 0.9×	1.3k 1.3×	249 0.8×	105 0.5×	137	4.2k
Harry Dolstra Netherlands	42	3.3k 2.2×	1.1k 1.1×	2.4k 2.5×	199 0.6×	275 1.2×	123	5.2k
Vanessa M. Hubbard-Lucey United States	17	910 0.6×	659 0.7×	1.4k 1.5×	159 0.5×	156 0.7×	23	2.4k
Lori Jones United States	21	1.5k 1.0×	549 0.6×	1.1k 1.1×	343 1.1×	234 1.0×	45	2.6k
Young J. Kim United States	19	936 0.6×	880 0.9×	665 0.7×	152 0.5×	68 0.3×	42	2.1k
Henrik Schmidt Denmark	27	1.8k 1.2×	1.1k 1.1×	2.6k 2.7×	161 0.5×	137 0.6×	96	3.6k
Christopher L. Hall United States	29	413 0.3×	1.2k 1.2×	1.0k 1.1×	299 0.9×	150 0.7×	62	2.8k

Countries citing papers authored by Eric W. Hoffman

Since Specialization

Citations

This map shows the geographic impact of Eric W. Hoffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric W. Hoffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric W. Hoffman more than expected).

Fields of papers citing papers by Eric W. Hoffman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric W. Hoffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric W. Hoffman. The network helps show where Eric W. Hoffman may publish in the future.

Co-authorship network of co-authors of Eric W. Hoffman

This figure shows the co-authorship network connecting the top 25 collaborators of Eric W. Hoffman. A scholar is included among the top collaborators of Eric W. Hoffman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric W. Hoffman. Eric W. Hoffman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smaletz, Òren, Maria Del Pilar Estevez-Diz, Sérgio Jobim Azevedo, et al.. (2021). Phase II consolidation trial with anti-Lewis-Y monoclonal antibody (hu3S193) in platinum-sensitive ovarian cancer after a second remission. International Journal of Gynecological Cancer. 31(4). 562–568. 7 indexed citations

Smaletz, Òren, Maria Del Pilar Estevez-Diz, Jorge Sabbaga, et al.. (2015). A phase II trial with anti-Lewis-Y monoclonal antibody (hu3S193) for the treatment of platinum resistant/refractory ovarian, fallopian tube and primary peritoneal carcinoma. Gynecologic Oncology. 138(2). 272–277. 22 indexed citations

Hoffman, Eric W., et al.. (2014). Exploring College Students’ Use of General and Alcohol-Related Social Media and Their Associations With Alcohol-Related Behaviors. Journal of American College Health. 62(5). 328–335. 83 indexed citations

López‐Jaramillo, Patricio, et al.. (2013). Asociación entre obesidad y baja capacidad muscular y función cardiorrespiratoria, factores de riesgo cardiometabólico en niños colombianos. Trauma. 24(1). 17–23. 2 indexed citations

Ott, Patrick A., Richard D. Carvajal, Neeta Pandit‐Taskar, et al.. (2012). Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma. Investigational New Drugs. 31(2). 425–434. 121 indexed citations

Kakimi, Kazuhiro, Midori Isobe, Akiko Uenaka, et al.. (2011). A phase I study of vaccination with NY‐ESO‐1f peptide mixed with Picibanil OK‐432 and Montanide ISA‐51 in patients with cancers expressing the NY‐ESO‐1 antigen. International Journal of Cancer. 129(12). 2836–2846. 66 indexed citations

Ott, Patrick A., Richard D. Carvajal, Neeta Pandit‐Taskar, et al.. (2009). Phase I/II study of arginine deiminase (ADI-PEG 20) in patients with advanced malignant melanoma (MM). Journal of Clinical Oncology. 27(15_suppl). 9030–9030. 5 indexed citations

Kageyama, Shinichi, Shigehisa Kitano, Yasuhiro Nagata, et al.. (2008). Humoral immune responses in patients vaccinated with 1–146 HER2 protein complexed with cholesteryl pullulan nanogel. Cancer Science. 99(3). 601–607. 95 indexed citations

Tsuji, Kazuhide, Akiko Uenaka, Hisashi Wada, et al.. (2008). Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient. Cancer Immunology Immunotherapy. 57(10). 1429–1437. 37 indexed citations

10.

Kawabata, Ryohei, Hisashi Wada, Midori Isobe, et al.. (2007). Antibody response against NY‐ESO‐1 in CHP‐NY‐ESO‐1 vaccinated patients. International Journal of Cancer. 120(10). 2178–2184. 58 indexed citations

11.

Sakamoto, Junichi, Noboru Oriuchi, Erito Mochiki, et al.. (2006). A phase I radioimmunolocalization trial of humanized monoclonal antibody huA33 in patients with gastric carcinoma. Cancer Science. 97(11). 1248–1254. 16 indexed citations

12.

Atanackovic, Djordje, Nasser K. Altorki, Elisabeth Stockert, et al.. (2004). Vaccine-Induced CD4+ T Cell Responses to MAGE-3 Protein in Lung Cancer Patients. The Journal of Immunology. 172(5). 3289–3296. 148 indexed citations

13.

Smith, C., P. Rod Dunbar, Fareed Mirza, et al.. (2004). Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence. International Journal of Cancer. 113(2). 259–266. 72 indexed citations

14.

Speiser, Daniel E., Mikäel J. Pittet, Philippe Guillaume, et al.. (2004). Ex Vivo Analysis of Human Antigen-Specific CD8+ T-Cell Responses: Quality Assessment of Fluorescent HLA-A2 Multimer and Interferon-γ ELISPOT Assays for Patient Immune Monitoring. Journal of Immunotherapy. 27(4). 298–308. 31 indexed citations

15.

Hoffman, Eric W.. (2003). The Future of “Philosophical Counseling”. 1(4). 1–13. 2 indexed citations

16.

Plötz, Paul H., Frederick W. Miller, Eric W. Hoffman, Livia Casciola‐Rosen, & Antony Rosen. (2001). Workshop on inflammatory myopathy Bethesda, 5–6 April 2000. Neuromuscular Disorders. 11(1). 93–95. 3 indexed citations

17.

Jäger, Elke, Sacha Gnjatic, Yasuhiro Nagata, et al.. (2000). Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proceedings of the National Academy of Sciences. 97(22). 12198–12203. 363 indexed citations

18.

Hoffman, Eric W., et al.. (1997). Bedeutung der Speicherelektrogramme zur Differenzierung adäquater und inadäquater ICD-Therapien. Herzschrittmachertherapie + Elektrophysiologie. 8(1). 39–45. 1 indexed citations

19.

Keyl, Cornelius, Peter Tassani, B. M. Kemkes, et al.. (1993). Hemodynamic changes due to intraoperative testing of the automatic implantable cardioverter defibrillator: Implications for anesthesia management. Journal of Cardiothoracic and Vascular Anesthesia. 7(4). 442–447. 18 indexed citations

20.

Bussey, Henry I. & Eric W. Hoffman. (1983). A Prospective Evaluation of Therapeutic Drug Monitoring. Therapeutic Drug Monitoring. 5(3). 245–248. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact